Trials / Completed
CompletedNCT03761758
Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- SightGlass Vision, Inc. · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
Prospective, randomized, subject-masked 3-arm clinical study to assess the pediatric acceptability across three iterations of a novel spectacle lens design.
Detailed description
This feasibility study was conducted to assess the performance of three experimental spectacle lens designs (spectacle lenses) in children between 6 and 9 years of age with myopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spectacle lenses | Spectacle lenses with clear central apertures |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2018-07-19
- Completion
- 2018-07-19
- First posted
- 2018-12-03
- Last updated
- 2018-12-03
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03761758. Inclusion in this directory is not an endorsement.